✦ LIBER ✦

SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons

✍ Scribed by George R. Breese; Robert A. Mueller

Book ID: 115879257
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 492 KB
Volume: 113
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(85)90349-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

D-2 dopamine antagonist-like effects of

D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons

✍ Jeffrey M. Goldstein; Linda C. Litwin; E.B. Sutton; Jeffrey B. Malick 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Selective D2 dopamine receptor agonists

Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist

✍ Emanuel Meller; Shigeki Kuga; Arnold J. Friedhoff; Menek Goldstein 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Binding of (+)PHNO and other D2-dopamine

Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390

✍ D. J. Pettibone; J. A. Totaro; B. V. Clineschmidt 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 239 KB

Grooming in the mouse is stimulated by t

Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390

✍ Beryl S. Starr; Michael S. Starr 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 294 KB

The "selective" dopamine D1receptor anta

The "selective" dopamine D1receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2Creceptors

✍ Mark J. Millan; Adrian Newman-Tancredi; Yann Quentric; Didier Cussac 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 59 KB

Attenuation of the locomotor-sensitizing

Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride

✍ Roy A. Wise; William A. Carlezon Jr. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Injections of the selective D, dopamine agonist bromocriptine (5.0 mg/ kg, IP) produced progressively stronger locomotion over 10 days of repeated testing. Concurrent treatment with either the D, antagonist SCH 23390 (0.01 or 0.1 mg/kg, IP) or the D, antagonist raclopride (0.1 or 1.0 mg/kg, IP) supp